Ivermectin Settlement Brings Relief And Worry For US FDA Communications

The FDA’s decision to end litigation challenging an agency communication that tried to tackle COVID-19 misinformation leaves an appeals court opinion in place that could haunt it later. But continuing to fight the case could have left the agency in a far worse position.

horse
Horse jokes are likely out at the FDA following a settlement over its ivermectin COVID-19 safety communications. • Source: Shutterstock

US Food and Drug Administration Commissioner Robert Califf faced a barrage of ivermectin misinformation from Republican lawmakers 12 April, who suggested the agency’s years-old FDA communications warning against using ivermectin, particularly versions approved for animal use, to treat COVID-19, and the resulting court case, were evidence of the agency’s inability to be trusted.

“Pretending that ivermectin is dangerous or claiming that it’s horse medicine, would you not agree that’s the exact definition of...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet